• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素(LHRH)激动剂与氟他胺联合雄激素阻断疗法对1例严重男性露阴癖患者的疗效。

Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism.

作者信息

Rousseau L, Couture M, Dupont A, Labrie F, Couture N

机构信息

La clinique d'évaluation et de traitement des troubles du comportement sexuel, Le centre de recherche Laval Robert-Giffard, Beauport, Québec.

出版信息

Can J Psychiatry. 1990 May;35(4):338-41. doi: 10.1177/070674379003500412.

DOI:10.1177/070674379003500412
PMID:2189544
Abstract

A severe exhibitionist has been treated with the combination of an LHRH agonist and the antiandrogen flutamide in order to maximize androgen blocking and to control his severe deviant behaviour. The results obtained show that the androgen blockade ended his exhibitionistic behaviour and markedly decreased his sexual fantasies and activities, especially masturbation, without significant side effects.

摘要

一名严重的露阴癖患者接受了促性腺激素释放激素(LHRH)激动剂与抗雄激素药物氟他胺联合治疗,目的是最大程度地阻断雄激素,并控制其严重的异常行为。所获得的结果表明,雄激素阻断结束了他的露阴行为,并显著减少了他的性幻想和性活动,尤其是自慰,且没有明显的副作用。

相似文献

1
Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism.促性腺激素释放激素(LHRH)激动剂与氟他胺联合雄激素阻断疗法对1例严重男性露阴癖患者的疗效。
Can J Psychiatry. 1990 May;35(4):338-41. doi: 10.1177/070674379003500412.
2
Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment?促性腺激素释放激素激动剂治疗严重性偏好障碍:一种终身治疗方法?
Psychoneuroendocrinology. 1996 May;21(4):411-9. doi: 10.1016/0306-4530(96)00004-2.
3
Plasma levels of hydroxy-flutamide in patients with prostatic cancer receiving the combined hormonal therapy: an LHRH agonist and flutamide.接受联合激素治疗(促性腺激素释放激素激动剂和氟他胺)的前列腺癌患者血浆中羟基氟他胺的水平
Prostate. 1988;12(1):79-84. doi: 10.1002/pros.2990120110.
4
Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dog.促黄体生成素释放激素(LHRH)激动剂[D-色氨酸6,去甘氨酰胺(10)]LHRH乙酰胺与抗雄激素氟他胺联合治疗2周对犬前列腺结构和类固醇水平的影响。
Mol Cell Endocrinol. 1989 Dec;67(2-3):131-8. doi: 10.1016/0303-7207(89)90202-5.
5
Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen.用促黄体生成素释放激素(LHRH)激动剂和纯抗雄激素治疗的前列腺癌患者中促黄体生成素生物活性的丧失。
Clin Endocrinol (Oxf). 1986 Jan;24(1):21-30. doi: 10.1111/j.1365-2265.1986.tb03250.x.
6
Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model.激动剂D-色氨酸-6-促黄体生成素释放激素(D-Trp-6-LH-RH)与抗雄激素氟他胺联合用于治疗邓宁R-3327H前列腺癌模型的研究。
Prostate. 1985;6(3):219-32. doi: 10.1002/pros.2990060302.
7
Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.接受纯抗雄激素治疗的前列腺癌去势患者以及接受促黄体生成素释放激素激动剂和抗雄激素治疗的雌激素预处理患者的血清促黄体生成素(LH)生物活性。
J Clin Endocrinol Metab. 1986 Aug;63(2):297-302. doi: 10.1210/jcem-63-2-297.
8
Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist.氟他胺可消除接受促黄体激素释放激素激动剂治疗的前列腺癌患者疾病复发的风险。
J Urol. 1987 Oct;138(4):804-6. doi: 10.1016/s0022-5347(17)43380-5.
9
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice.对于既往未经治疗的临床D2期前列腺癌患者,氟他胺与去势(促黄体激素释放激素激动剂或睾丸切除术)联合治疗:当今的首选治疗方法。
J Steroid Biochem. 1988;30(1-6):107-17. doi: 10.1016/0022-4731(88)90083-0.
10
Effect of 3-week treatment with [D-Trp6, des-Gly-NH10(2)]LHRH ethylamide, aminoglutethimide, ketoconazole or flutamide alone or in combination on testicular, serum, adrenal and prostatic steroid levels in the dog.单独或联合使用[D-色氨酸6,去甘氨酰胺10(2)]促黄体生成素释放激素乙酰胺、氨鲁米特、酮康唑或氟他胺进行3周治疗对犬睾丸、血清、肾上腺和前列腺类固醇水平的影响。
J Steroid Biochem. 1989 Aug;33(2):233-42. doi: 10.1016/0022-4731(89)90299-9.

引用本文的文献

1
Pharmacological Interventions in Paraphilic Disorders: Systematic Review and Insights.性偏好障碍的药物干预:系统评价与见解
J Clin Med. 2024 Mar 7;13(6):1524. doi: 10.3390/jcm13061524.
2
Current concepts in the pharmacotherapy of paraphilias.当前性癖障碍药物治疗的概念。
Drugs. 2011 Apr 16;71(6):771-90. doi: 10.2165/11585490-000000000-00000.